
Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31, 2023.
Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31, 2023.
We’re thrilled to announce that Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31, 2023.
Joining us at the conference will be our very own Sarah Carl, Diana Stoycheva, and Julian Spagnuolo. We’re incredibly excited to share that Sarah will give a presentation on Day 1, Thursday, March 30th, at 9:20 am in Room 1. She’ll be discussing “Discovering next-generation biomarkers through integrating single-cell ‘omics and artificial intelligence.”
If you’re attending NextGen Omics Boston, we hope you’ll come and listen to Sarah’s presentation and stop by booth number 14 to learn more about Scailyte’s cutting-edge work in the field of single-cell analysis. We’re looking forward to connecting with other researchers, innovators, and leaders in the field of genomics.
See you in Boston!
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
Scailyte Extends Series A to USD 8 Million
We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...
Recent News
ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology
Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...
Recent News
Pitch-nic Expo
We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...
Recent News
Targets & Cell Types in Immuno-Oncology Europe 2023
Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...
Recent News
Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs
We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...
Recent News
NextGen Omics 2023
Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...
Recent News
Recent News
ScaiDigest Volume 5: Unlocking the Secrets of AML
Read Diana's insightful post and stay at the forefront of scientific advancements in the field!
Recent News
Scailyte Extends Series A to USD 8 Million
We are thrilled to announce the extension of our Series A funding, bringing the total raised amount ...
ScaiDigest Volume 6: Variational autoencoders (VAEs) in biology
Welcome to the 6th edition of ScaiDigest, where we explore cutting-edge research in single-cell anal...
Recent News
Pitch-nic Expo
We're excited to share that our Senior Vice President of Corporate & Technology Development, Corinne...
Targets & Cell Types in Immuno-Oncology Europe 2023
Scailyte is part of Targets & Cell Types in Immuno-Oncology Europe 2023 event on November 14-15 in B...
Recent News
Unravelling the AI Executive Order: A Discussion with Our CEO and Head of Regulatory Affairs
We invite you to watch this enlightening discussion to gain valuable insights into the evolving AI l...
NextGen Omics 2023
Scailyte is gearing up for NextGen Omics 2023, one of the most scientifically engaging events in Lon...
Recent News
SITC 2023
Diana Stoycheva and Julian Spagnuolo will be sharing Scailyte’s science at a poster #201, and will...
ScaiDigest Volume 5: Unlocking the Secrets of AML
Read Diana's insightful post and stay at the forefront of scientific advancements in the field!